BEDMINSTER, N.J., Feb. 07, 2025 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) today announced the appointment of Evelyn D’An to its Board of Directors as an independent director and Chair of the Audit Committee, effective Wednesday, February 5, 2025.
Matinas BioPharma Appoints Evelyn D’An to Board of Directors as Audit Committee Chair
Seeking Alpha / 2 hours from now 1 Views
Comments